SottoPelle Cost in 2026: What Women Pay—and the 4 Fees Quotes Miss

Educational research — not medical advice, and not medically reviewed by a clinician.

Researched and produced by The HRT Index editorial team under The HRT Index Verification Standard.

Last verified: August 2026

SottoPelle cost is currently $350 to $425 per insertion on first-party clinic pages and indexed first-party listings. That becomes $700 to $1,700 a year at two to four insertions, before any separately billed consultation, labs, progestogen, booster, membership, or complication care. There is no national patient price; each clinic sets its own.

The three numbers that matter

Number	What it actually means
$350–$425 per insertion	The current published band we found for women on SottoPelle-branded first-party clinic pages and indexed first-party listings, checked August 25, 2026. It is a small, non-random sample—not a national average.
$700–$1,700 per year	Pellet insertion fees only at two to four insertions a year. Three to four insertions produces a narrower $1,050–$1,700 band.
Unknown until itemized	Consultation, baseline and follow-up labs, progestogen when required, a booster, membership charges, and the clinic’s policy if a pellet extrudes or the insertion site needs treatment.

Best for / not for you if

This page is for you if:

• You received a SottoPelle quote and want to know what it leaves out.
• You want a first-year number, not a per-insertion sticker.
• You are comparing pellets with a patch, pill, gel, cream, ring, or another clinician-directed route.
• You want the questions that force a clinic to put the real cost in writing.

SottoPelle may not be your route if:

• You have not compared an FDA-approved menopause hormone therapy option yet.
• You want to use insurance for the treatment itself.
• You want a dose that can usually be changed or stopped quickly.
• Your clinic will not name the compounding facility, itemize the quote, or explain what happens after insertion.
• Your symptoms or risk history belong with an in-person specialist before online or elective hormone care.

Where our money comes from, before you read our numbers

We earn nothing from SottoPelle, any SottoPelle-certified clinic, or any pellet provider. We may earn a commission if you start care with some online providers named or linked later on this page.

So our incentive runs against pellets. You should read this knowing that.

That is why every current price here is tied to a named first-party source, every payer finding carries a policy number and date, and every older document is labeled as older instead of being smuggled into a 2026 average. Read our full affiliate disclosure.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

The right route is not the same for every woman

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

Find My HRT Path →

What we actually verified

We verified: four current published or indexed first-party prices; SottoPelle's provider-facing pricing model and directory disclaimer; two conflicting historical fee documents that expose the booster question; four current insurer policies; the current Tutera membership terms; FDA compounding statements; the current Testopel label; the federal Schedule III status of testosterone; specialty guidance; and peer-reviewed comparative pellet data.

We did not verify: one national SottoPelle average, your dose, your required insertion frequency, an unpublished local quote, your personal insurance benefits, or any outcome promised in a testimonial. We did not call the clinics, so prices labeled as indexed rather than live-page verified should be confirmed in writing before payment.

We are not clinicians. This page has not been medically reviewed. It is independent editorial research. Where the public evidence does not support a definitive answer, the page says exactly what remains unknown.

---

How much does SottoPelle cost in 2026?

The current published SottoPelle price band for women is $350 to $425 per insertion. The annual pellet-only number is $700 to $1,700 at two to four insertions, while Tutera Medical's own stated average of 3.5 insertions produces $1,242.50 to $1,435 a year before separately charged services.

Here is the part your search probably did not resolve.

SottoPelle has a page called “Pricing,” but it is not a national patient price list. It sells provider training, access to a dosing calculator, clinical support, directory placement, marketing materials, and purchasing access for pellets and insertion supplies. The local practice decides what a woman pays. That is why the authoritative brand page can be real and still fail to answer the question you typed.

So we found the practices that publish.

The SottoPelle price ledger — checked August 25, 2026

Confidence key: High means the price appears on a live first-party page we opened. Medium-high means current first-party indexed text and a related live first-party page support the price or inclusions, but the original pricing URL now redirects. Medium means a current indexed first-party shop result exposes the price while the rendered shop page does not expose readable text.

Clinic / location	Women's published price	What the source says	Annual pellet-only math	Evidence status
Radiant Wellness & Weight Loss — Jonestown, Texas	$350	Current first-party shop result lists “SottoPelle Pellets (Female).” Inclusions and frequency are not stated.	$700 / $1,050 / $1,400 at 2 / 3 / 4 insertions	Medium — indexed first-party shop text; confirm the live checkout price
Tutera Medical — Arizona	$355–$410	Current membership page uses this women’s pellet range and says women average 3.5 insertions a year. Products and services are purchased separately from membership.	$1,242.50–$1,435 at the page’s stated 3.5 average	High — live first-party page
Gudgel Aesthetics — Norman / South Oklahoma City, Oklahoma	$400	Current first-party pricing text says a new female pellet insertion includes follow-up labs as needed.	$800 / $1,200 / $1,600 at 2 / 3 / 4 insertions	Medium-high — current first-party indexed text plus live related page
Austin Labiaplasty & Vaginal Rejuvenation — Austin, Texas	$425 per insertion	Live pricing page says consultation and labs are needed before therapy. It does not say those items are included in the $425.	$850 / $1,275 / $1,700 at 2 / 3 / 4 insertions	High — live first-party page

Primary price sources: Radiant Wellness first-party shop, Tutera Medical membership, Gudgel Aesthetics hormone pricing, and Austin Labiaplasty pricing.

The honest limit of that table

Four prices are not a market survey. Clinics that publish are self-selected, and most SottoPelle providers still make you call before they disclose a number.

So we are not averaging the rows into a fake national figure. The table is an observed, source-dated negotiating band. It tells you what named practices publicly attach to the service; it does not tell you what every clinic charges or what your dose will cost.

What it can do is stop you from walking into a consult blind. A $500 quote may be reasonable if it includes labs, follow-up, and complication support. A $350 quote can become the expensive one if every other line is separate. Compare structures, not stickers.

Frequency beats price

Take the per-insertion amount you were quoted and call it P.

Reinsertion schedule discussed with your clinician	Insertions per year	Pellet-only annual cost
Every 6 months	2	P × 2
Every 4 months	3	P × 3
Every 3 months	4	P × 4

At $400, that is $800, $1,200, or $1,600. Same per-insertion quote. Double the annual spend.

This is budgeting math, not a dosing recommendation. Ask the clinic to put its expected first-year insertion count for women in writing—and to tell you what would make that count change.

---

Why does every SottoPelle clinic charge something different?

SottoPelle is a provider-training, dosing-method, support, and directory network—not one national clinic chain with one patient checkout price. Each local practice controls its consultation fee, insertion price, lab policy, follow-up schedule, membership terms, and complication policy.

That distinction explains nearly every frustrating search result you found before this one.

The brand controls access to a method. The practice controls your bill.

SottoPelle's provider-facing page sells training and support packages. Those packages include access to dosing tools, clinical support, provider-directory features, office materials, marketing resources, and purchasing access for pellets, trocars, and related supplies.

Your local practice decides:

• The consultation fee.
• Whether price changes with pellet count or dose.
• Whether baseline or follow-up labs are bundled.
• How often follow-up happens and who performs it.
• Whether a booster is used.
• Whether a membership is required or optional.
• Whether the practice bills insurance, provides a superbill, or stays cash-pay.
• What happens if the insertion site needs care or a pellet extrudes.

Every line that reaches your credit card is set locally.

A directory listing is not a full quality check

SottoPelle's own terms say the site does not verify participating professionals' active licenses, credentials, disciplinary history, or malpractice insurance. The terms also say SottoPelle does not recommend or endorse the professionals or warrant the quality of care they provide.

That is a normal directory disclaimer. But it means the logo answers a training-network question—not your complete price question and not your complete quality question.

Here is the damaging admission, and it belongs to the brand model, not to us: SottoPelle branding does not tell you whether a clinic is transparent, whether the person inserting the pellet is the prescriber, or whether the after-hours plan is any good. You still have to verify those things yourself.

Sources: SottoPelle provider pricing and SottoPelle terms of use.

Even SottoPelle's public duration language varies

How often you pay is the largest controllable number on this page, yet SottoPelle's own public pages use several ranges for women.

SottoPelle source	Public duration language for women
Main site	Patient-reported duration of 4–6 months
Provider-training article	Up to 3 months
Provider article	3–6 months on average
Consumer article	3–4 months

Those statements are not a schedule for you. They are proof that no single duration should be multiplied into a universal annual price.

Sanity-check any quote: multiply the per-insertion price by the clinic's expected first-year count, then ask, “What percentage of your women return at three months, four months, five months, and six months?” If the answer is “it depends,” that is fine. The next sentence should explain what it depends on and what the clinic typically sees.

---

What is not included in a SottoPelle quote?

An insertion quote does not automatically include the consultation, baseline or follow-up labs, clinician-directed progestogen when systemic estrogen is prescribed to a woman with a uterus, a possible booster, membership charges, or care after an extrusion or insertion-site problem. The clinic must itemize each line.

This is the section we built the page for. Take it into the clinic.

Fee 1: A booster insertion

A booster is not a universal SottoPelle fee. It is a question created by a real, published clinic fee structure—and the public documents are messier than the original version of this page admitted.

Allura Clinic currently hosts two old documents for a program that uses the SottoPelle method:

• A fee sheet explicitly labeled “Fees as of September 2019” lists a $215 female booster 5–7 weeks after the initial insertion, a $150 consultation, and $290 maintenance insertions.
• A separate undated FAQ lists a $185 female booster, a $100 consultation, and $270 maintenance insertions.

Those documents conflict. Neither belongs in a 2026 headline price band. But together they prove something more useful: a clinic can build an extra insertion into year one that a per-insertion quote never warned you about.

That is not a reason to assume your clinic uses boosters. It is a reason to ask.

Ask this word for word: “Is a booster insertion part of your standard first-year process, under what circumstances would you recommend one, and what would I pay?”

Sources: Allura fee sheet—fees as of September 2019 and Allura's separate undated FAQ.

Fee 2: Labs—and “labs included” is not a complete sentence

The current clinic sources show three different structures:

• Austin says consultation and labs are needed before treatment but does not say they are included in the $425 insertion price.
• Gudgel's current indexed price says follow-up labs are included with the $400 female insertion.
• Allura's older FAQ says cash patients can prepay reduced Labcorp rates separately.

So “labs included” still leaves six questions:

1. Are baseline labs included?
2. Are post-insertion labs included?
3. Are repeat labs required before every reinsertion?
4. Is the blood-draw or specimen fee included?
5. Can your insurance be billed for the labs even if the pellet is cash-pay?
6. What happens when the clinician orders a repeat or expanded panel?

ACOG's 2023 clinical consensus says evidence for interpreting adjunct hormone tests to prescribe and dose compounded menopausal hormone therapy is limited. That does not make a clinic's test order automatically improper. It does mean the recurring lab schedule is a clinical and financial choice you are allowed to have explained.

Fee 3: Progestogen when your regimen includes systemic estrogen

If you still have your uterus and your clinician prescribes systemic estrogen, The Menopause Society says estrogen must be paired with a progestogen to protect against uterine cancer. Do not assume that protection is inside the pellet quote.

SottoPelle's public materials focus mainly on estradiol and testosterone pellets, while other brand content discusses progesterone in broader training contexts. The current price pages in our ledger do not clearly say a progestogen is included.

So the correct question is not “Does SottoPelle always include progesterone?” It is:

“I have a uterus. If my plan includes systemic estrogen, what progestogen will protect the uterine lining, in what form, on what schedule, and what will it cost?”

Do not accept “we balance your hormones” as the answer. Get the actual medication, route, schedule, prescriber, and pharmacy in writing.

Fee 4: What happens if the insertion needs follow-up care

Two sources establish why this belongs in a cost discussion, but neither is a SottoPelle complication-rate study.

The current Testopel label—written for a different testosterone pellet product and male indications—documents postmarketing insertion-site infection and pellet extrusion, says most reported cases occurred within the first month, and says further treatment may be required. The FDA's 2019 statement about BioTE—also a different company—reported that an inspection uncovered 4,202 previously unreported adverse-event records; incomplete information allowed the agency to attribute 61 events, including extrusion and cellulitis, to compounded testosterone pellets.

Neither source is a finding against SottoPelle. Both show why an implantation clinic should have a written policy for site problems, replacement, and urgent follow-up.

Ask:

“If a pellet extrudes or the insertion site becomes infected, who sees me, what does that visit cost, and under what conditions is replacement included?”

A cost page that assigns zero dollars to every possible follow-up is not a cost page. It is a brochure.

The eight-bucket quote map

Cost bucket	Ask this exact question	Why it changes your total
Initial consultation	“Is the consultation separate, and is any part credited toward treatment?”	One-time first-year cost; sometimes bundled, sometimes not
Baseline labs	“Which tests, which lab, and who bills me?”	May be cash-pay, insurance-billed, or included
Pellets + insertion	“Does this fee cover every prescribed pellet, supplies, anesthetic, and placement?”	Some clinics tie price to pellet count or dose
Booster	“Could I need another insertion 5–7 weeks later, and what would it cost?”	Can add an unexpected first-year procedure
Follow-up visits	“How many are included, and will I see the prescriber?”	Monitoring may be separate or bundled
Follow-up labs	“Are both baseline and post-insertion labs included?”	“Labs included” may mean only one set
Progestogen / other prescriptions	“What else will be prescribed, from which pharmacy, and is it included?”	Recurring pharmacy cost outside the pellet fee
Complication care	“If the site needs treatment or a pellet extrudes, what is covered?”	Unplanned visit, treatment, or repeat placement

Optional buckets that catch people out: membership fees, a 12-month commitment, financing interest, supplements, missed-appointment fees, travel, time off work, and after-hours care.

You now have the four questions a headline quote cannot answer. Take the full 15-question SottoPelle quote sheet into the consultation and ask for the answers in writing.

---

How much will SottoPelle cost in your first year?

Your first-year SottoPelle total is the insertion price multiplied by the actual number of insertions, plus any consultation, booster, labs, follow-up, membership, additional prescriptions, and uncovered aftercare. Current public pellet-only examples run from $700 at two $350 insertions to $1,700 at four $425 insertions.

Most cost pages multiply one number by three and call the job finished. That is how a plausible answer becomes a wrong one.

Run your quote through the current published band

Scenario	Transparent arithmetic	Pellet-only total
Lowest current published price, 2 insertions	$350 × 2	$700
Lowest current published price, 3 insertions	$350 × 3	$1,050
Tutera published range at its stated 3.5 average	$355–$410 × 3.5	$1,242.50–$1,435
Highest current published price, 3 insertions	$425 × 3	$1,275
Highest current published price, 4 insertions	$425 × 4	$1,700

Every line above excludes any item the clinic bills separately.

Two formulas worth writing down

First-year total = (insertion price × first-year insertions) + consultation + booster + baseline labs + follow-up labs + follow-up visits + additional prescriptions + membership + uncovered aftercare

Renewal-year total = recurring insertions + recurring labs + recurring visits + recurring prescriptions + membership

They are not the same number. A clinic saying “about $1,200 a year” may be quoting a stable renewal year while you are hearing a complete first year.

What the older Allura documents reveal about structure—not current price

The September 2019 fee sheet creates a useful historical model:

Historical line item	Published 2019 amount
Consultation only	$150
Initial insertion, including consultation and pellets	$340–$370
Booster at 5–7 weeks	$215
Maintenance insertion	$290

Under that old schedule, initial + booster + two maintenance insertions equaled $1,135–$1,165; adding a third maintenance insertion equaled $1,425–$1,455. Those are not 2026 Allura quotes. They are proof that the shape of year one can be different from the shape of later years—and proof that two documents from the same clinic can disagree.

The takeaway is not “budget $215 for a booster.” The takeaway is: make the clinic draw your first 12 months as a timeline before you pay for month one.

The first-year timeline question

Ask the clinic to complete this sentence:

“If I start on _______, the appointments, labs, prescriptions, and possible procedures you expect during my first 12 months are ____, and the price of each is _______.”

That single line is more valuable than a national average because it turns a sales quote into a care plan you can audit.

---

Do you need a separate progestogen with SottoPelle?

If you have a uterus and your SottoPelle plan includes systemic estrogen, you need clinician-directed endometrial protection with a progestogen. The public insertion prices we verified do not establish that it is included, so treat the medication, route, monitoring, and pharmacy cost as separate until the clinic puts them in writing.

This is not a small billing detail. It is part of the treatment plan.

What the specialty guidance says

The Menopause Society states that a woman who still has a uterus and uses systemic estrogen needs estrogen-plus-progestogen therapy to protect against uterine cancer. FDA-approved bioidentical estradiol and progesterone options exist; “bioidentical” does not automatically mean compounded.

Do not let a general promise about “balance” replace the specific protection plan. Ask for the drug name, route, dose schedule, what bleeding should trigger a call, and how the clinician will respond if bleeding occurs.

The direct comparative data is not reassuring

A 2021 retrospective chart review in Menopause compared 384 postmenopausal women using pellet hormone therapy with 155 using FDA-approved hormone therapy. Among women who had a uterus when therapy began:

• 55.3% (136 of 246) in the pellet group had at least one episode of abnormal uterine bleeding.
• 15.2% (12 of 79) in the FDA-approved group had at least one episode.
• 20.3% (50 of 246) in the pellet group underwent hysterectomy, versus 6.3% (5 of 79) in the FDA-approved group.

The pellet group also had higher mean peak estradiol and testosterone levels. This was a retrospective chart review, not a randomized trial, and it was not a SottoPelle-specific study. It cannot prove that the route alone caused every difference. It is still large enough and direct enough that a price page cannot responsibly bury it.

Source: Jiang et al., Menopause 2021.

The older endometrial study needs the right denominator

A 2007 retrospective study followed 258 postmenopausal women receiving estradiol and testosterone implants. Forty-four developed an endometrial thickness greater than 5 mm; among those 44 selected women, 20.4% had simple endometrial hyperplasia on biopsy.

That is not 20.4% of all 258 women. The denominator matters. The finding still reinforces the need for a real endometrial-protection and bleeding plan rather than a vague add-on.

Source: Filho et al., Gynecological Endocrinology 2007.

Ask before insertion, not after bleeding starts

Use this sentence:

“I have a uterus. If this plan includes systemic estrogen, what progestogen will I use, how will it be prescribed, what is the separate cost, and what is your protocol if I bleed?”

If the answer is vague, slow down. A clear clinic should be able to explain a clear plan.

---

Does insurance cover SottoPelle?

None of the four current payer policies we reviewed supports routine coverage of implantable estradiol pellets for menopause. The policies classify estradiol pellets or menopause-related pellet use as investigational, experimental, unproven, or non-covered; your office visit and standard lab claims may still be processed separately under your specific plan.

That is more precise than “insurance never covers pellets,” and it gives you something you can actually use with a benefits representative.

The payer ledger — checked August 25, 2026

Payer / policy	Current date	What the policy says about the use relevant here
Aetna CPB 0345 — Implantable Hormone Pellets	Last reviewed July 8, 2026	Implantable estradiol pellets are experimental, investigational, or unproven. CPT 11980 is annotated as covered for testosterone only—not estradiol. Menopausal and perimenopausal diagnosis codes N95.0–N95.9 appear in the not-covered table.
Capital Blue Cross Medicare Advantage MA 2.345	Effective February 1, 2026	Subcutaneous estradiol pellets are investigational. Testosterone-pellet use for postmenopausal symptoms is also listed as investigational. The policy applies to the carrier's Medicare Advantage plans.
BlueCross BlueShield of South Carolina CAM 019	Annual review April 1, 2026	Implanted estrogen pellets and testosterone pellets for menopause symptoms are investigational; bioidentical hormone replacement implants are not a covered benefit under the policy.
Blue Cross Blue Shield of North Dakota S-32-014	Last reviewed March 11, 2025; current page checked August 2026	Testosterone pellets for menopausal symptoms or reduced libido are non-covered; estradiol, estrogen, or estrogen-plus-testosterone pellets are experimental/investigational and non-covered.

Policies: Aetna CPB 0345, Capital Blue Cross MA 2.345, BCBS South Carolina CAM 019, and BCBS North Dakota S-32-014.

The Aetna code pair that explains the denial

Aetna's current policy puts two lines beside each other:

• CPT 11980, subcutaneous hormone pellet implantation, is listed with the note “covered for testosterone only—not estradiol.”
• ICD-10 N95.0–N95.9, menopausal and other perimenopausal disorders, appears in the not-covered diagnosis table.

The procedure code exists. The use you are asking the plan to cover is carved out.

That is the mechanical reason a clinic can hand you a valid procedure code and still tell you the menopause pellet treatment is cash-pay. It is not accurate to say no billing code exists. The problem is that the policy excludes the drug/use/diagnosis combination relevant to the visit.

What an insurance policy proves—and what it does not

“Investigational,” “experimental,” or “unproven” is coverage language tied to a plan's evidence threshold. It is not the same thing as a finding that a clinician acted illegally, and it does not prove your individual contract will process every line identically.

Employer plans, state rules, and benefit designs can differ. A current policy is strong evidence of how the carrier approaches the service; your plan document and claim decision control your bill.

Ask five coverage questions, not one

“Does insurance cover SottoPelle?” is too blunt. Split the bill:

1. Is the consultation covered?
2. Are the ordered labs covered?
3. Is the compounded medication covered?
4. Is the insertion procedure covered?
5. Are the follow-up visits covered?

Then get identifiers rather than promises: the practice's legal name, the prescriber's name and NPI, the procedure and diagnosis codes the clinic expects to use, the lab vendor, the compounding facility, and whether the office submits claims or gives you a superbill.

A superbill is documentation. It is not reimbursement.

If you have PPO insurance you would rather use, resolve that before you pay cash for an implant. Compare insurance-oriented and cash-pay options in our best online HRT providers for menopause guide or use Find My HRT Path to filter by your plan, state, symptoms, and medication-route preference.

---

Can you use HSA or FSA money for SottoPelle?

A clinic may accept an HSA or FSA card for SottoPelle, but card acceptance is not the same as a plan administrator confirming the expense is eligible. Get an itemized receipt and verify the service under your account rules before relying on pre-tax funds.

The historical Allura fee sheet explicitly lists HSA debit cards among accepted payment methods. That proves at least one pellet clinic has processed the card; it does not create a universal eligibility rule.

Keep these separate:

• Insurance coverage means the plan pays or reimburses part of a covered claim.
• HSA/FSA payment means you use your own tax-advantaged account for an eligible expense.

Ask the clinic for an itemized receipt with the patient name, date, prescriber or practice, service description, and amount. If the administrator asks for a letter of medical necessity or other documentation, get it before the submission deadline.

And remember: HSA/FSA funds can also be used for many FDA-approved prescriptions and eligible clinical visits. Account eligibility is not a reason by itself to choose pellets over another route.

---

Is SottoPelle FDA-approved?

SottoPelle is a training method, brand, and provider network—not an FDA approval status. The estradiol and testosterone pellets used for women are compounded, and compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, and quality in the way an approved finished drug is.

Four terms get blurred in pellet marketing. Keep them separate.

Term	What it means
Bioidentical	A hormone has the same chemical and molecular structure as a hormone the body produces. Both FDA-approved and compounded products can fit this description.
FDA-approved	FDA reviewed a specific finished product for specified uses, manufacturing controls, labeling, safety, and effectiveness.
Compounded	A pharmacy or outsourcing facility prepares a medication under the federal and state compounding framework. The finished compounded drug is not FDA-approved.
Off-label	A licensed prescriber uses an FDA-approved drug outside its approved labeling. That may be lawful and clinically appropriate, but the unlisted use itself is not an FDA approval.

Read the first row twice. “Bioidentical” does not mean compounded, and it does not mean FDA-approved. The Menopause Society notes that many well-tested, FDA-approved hormone products are bioidentical.

What FDA and specialty guidance say

• The FDA says compounded drugs are not FDA-approved and the agency does not verify their safety, effectiveness, or quality before marketing.
• ACOG's 2023 clinical consensus says compounded bioidentical menopausal hormone therapy should not routinely be prescribed when FDA-approved formulations exist. Based on the lack of safety data and inability to remove the pellet, ACOG recommends preparations other than pellets for delivering testosterone.
• The Menopause Society says custom-compounded hormones are not safer or more effective than approved bioidentical hormones and are not tested to establish predictable absorption.

That does not make every compounded prescription illegitimate. Compounding can meet a real medical need when an approved product cannot. It does mean the clinic should be able to explain why this compounded route fits you better than an available approved route—not merely say “natural.”

The 2019 FDA adverse-event finding is about BioTE, not SottoPelle

During a 2018 inspection of BioTE Medical, the FDA found information about 4,202 adverse events that had not been reported to the agency. Because much of the information was incomplete, the FDA could attribute 61 events—including pellet extrusion and cellulitis—to compounded testosterone pellets.

This was BioTE, a different company. It was not a regulatory finding against SottoPelle. It belongs on this page because it is a major federal compounding-and-pellet event, not because it can be reassigned to the brand you searched.

Source: FDA statement, September 9, 2019.

Testosterone deserves its own paragraph

If your plan includes testosterone:

1. Testosterone is a Schedule III controlled substance in the United States. It requires a prescription and a legitimate prescriber-patient process. Federal scheduling appears in 21 CFR § 1308.13.
2. There is no FDA-approved testosterone product indicated for women in the United States. Prescribing an approved male product to a woman would be off-label; a compounded testosterone preparation remains non-FDA-approved.
3. The FDA-approved Testopel label is for male hypogonadal indications, not women. The current label classifies the product as CIII and warns that pellet dosing is less flexible than oral or injectable dosing.
4. ACOG recommends a route other than pellets for testosterone in women because of the lack of safety data and the difficulty of reversing the dose once implanted.

None of that means a prescription is automatically unlawful or that a clinician cannot make an individualized decision. It means the marketing phrase “bioidentical pellet” does not erase the prescription, controlled-substance, off-label, and compounding facts.

Ask which facility compounds the pellets

SottoPelle says its method uses pellets from 503B outsourcing facilities. Ask the clinic for the exact facility name and verify it rather than stopping at “503B.”

A 503A pharmacy generally compounds for an identified patient under a valid prescription. A registered 503B outsourcing facility can compound with or without patient-specific prescriptions and is subject to current good manufacturing practice requirements and FDA risk-based inspection. Neither label makes the finished compounded drug FDA-approved.

Use the FDA's 503A/503B comparison to verify what the clinic tells you.

---

Is the Tutera Medical membership worth it for SottoPelle?

Tutera Medical's current Essential HRT + Aesthetics membership costs $49.99 a month with a 12-month commitment, not $99.99. That is $599.88 a year before treatment. The page's stated women's pellet savings of $159.75 to $184.50 recover about 27% to 31% of the monthly-pay annual fee.

This is the largest factual correction in the original draft.

The $99.99 price belongs to Tutera's separate Signature “Complete Metabolic Optimization” tier. The HRT-focused Essential tier is $49.99 a month. Both show a 12-month commitment, and products and services are purchased separately at discounted member prices.

The corrected membership math

Item	Current published figure or transparent calculation
Essential membership	$49.99/month
Commitment	12 months
Annual fee when paid monthly	$599.88
Prepaid annual price after the published 10% membership discount	$539.89
Pellet discount	15%
Women's pellet range used on the page	$355–$410
Stated annual women's pellet savings	$159.75–$184.50
Gap after stated pellet savings—monthly-pay membership	$415.38–$440.13
Gap after stated pellet savings—prepaid membership	$355.39–$380.14
Are pellets or services included?	No

Source: Tutera Medical membership page, checked August 25, 2026.

The page's own savings example does not reconcile

Tutera says women average 3.5 insertions a year at $355–$410, with a 15% pellet discount. But the displayed annual savings of $159.75–$184.50 equals 15% of three insertions, not 3.5.

Using the page's stated 3.5 average, the pellet discount would calculate to approximately $186.38–$215.25 a year. That does not make the membership deceptive. It means the public example contains an arithmetic mismatch you should not inherit without checking.

What that means, said fairly

The page lists other benefits: aesthetic discounts, red-light therapy, and a weekly energy booster. A woman who genuinely uses those services may recover more than the pellet discount alone. That is a real use case.

But if you are joining only to make pellets cheaper, the pellet discount alone does not pay for the membership. You still need roughly $355 to $440 of value from other included or discounted services, depending on payment method and which savings number you use.

Before signing, ask:

• Is the 12-month commitment cancellable for a medical reason or if treatment stops?
• Does it auto-renew after month 12?
• What is the exact discounted pellet price for your prescribed dose?
• Are labs, visits, and other prescriptions discounted?
• Do benefits and prices vary by location?
• What happens to unused benefits?

The public page gives the commitment and price. It does not give enough cancellation detail to assume an easy exit.

---

Is SottoPelle the same as BioTE?

No. SottoPelle and BioTE are different commercial training, protocol, and provider-network businesses. Neither name turns a compounded pellet into an FDA-approved drug, and because local practices set patient prices, the clinic's written quote and compounding source matter more than a brand-to-brand sticker comparison.

Austin Labiaplasty, a practice offering SottoPelle, publicly states that BioTE's founder started that company after leaving SottoPelle. That explains the shared lineage without making the companies interchangeable.

The better buying question is not simply “Which logo is better?” It is:

• Who prescribed the medication?
• Who performs the insertion?
• Which exact facility compounded it?
• What hormones and dose are prescribed?
• What evidence and clinical reasoning support the route?
• What is included in the first-year bill?
• What happens if the dose or insertion site becomes a problem?

A clinic that will not name the compounding facility has answered a quality question by refusing to answer it.

---

What does FDA-approved menopause treatment cost instead?

There is no single alternative price because FDA-approved menopause care can be insurance-billed or cash-pay, and the medication depends on symptoms, uterus status, risk history, and route. The useful comparison is structural: pellets charge for recurring procedures, while patch, pill, gel, ring, or vaginal products separate the clinical visit from the prescription.

The point of this table is not to pretend the routes are medically interchangeable. It is to show what you are buying and where the bill moves.

Route	Current published cost structure	Medication status	What can change quickly?	Main cost question
SottoPelle at a local clinic	$350–$425 per insertion in the current published sample; $700–$1,700 at 2–4 insertions before separately billed items	Women's estradiol/testosterone pellets are compounded, not FDA-approved finished products	Dose is not readily titratable after insertion; removal may be possible when clinically necessary but is not routine	How many insertions, labs, visits, prescriptions, and uncovered follow-ups are in year one?
Insurance-oriented telehealth, using Midi as a current example	Self-pay visits are $250 initial / $150 follow-up; insurance cost depends on the exact state, carrier, and plan; prescriptions and labs are separate	FDA-approved menopause prescriptions are available; Midi also offers some clearly labeled compounded options, so confirm the exact prescribed product	A patch, pill, gel, or cream can generally be changed or stopped under clinician direction without waiting for an implant to dissolve	Is the visit in-network, which medication is prescribed, and what will the pharmacy and lab benefits pay?
Cash-pay telehealth, using Winona as a current example	Published prices include an FDA-approved estradiol patch from $149/month, estrogen tablets from $54/month, FDA-approved progesterone capsules from $39/month, and compounded creams from $89/month	Mixed: the patch, tablets, and capsules are labeled FDA-approved; creams are compounded	Non-implant routes can generally be adjusted with the prescriber	Which exact products are in your protocol, and what is the checkout total—not the lowest single-item price?
Your existing clinician + retail pharmacy	Visit, lab, and prescription costs depend on plan benefits, drug, dose, and pharmacy	FDA-approved generic and brand options are available	Depends on route, but non-implant dosing is generally more adjustable	What does your formulary cover, and does the clinician have menopause expertise?

Source: Midi pricing and insurance, Winona treatment prices, and Winona estradiol patch. Prices checked August 25, 2026. Midi says its general midlife care is available in all 50 states; Winona says its physician telehealth care is available nationwide. A particular medication program can still have state-specific limits. “From” prices are provider-stated entry prices, not a promise that your full regimen will cost that amount.

One honest problem with the alternative

An insurance-oriented telehealth clinic does not give you a pellet. There is no procedure and no months-long implant. If the set-it-and-forget-it route is the feature you value most, a patch or pill is not the same product with a nicer price.

And the cash-pay visit can sting. Midi's $250 initial self-pay appointment is more than some historical booster or maintenance fees. The economic case rests on the structure that follows—the potential to use insurance, the absence of a recurring implantation fee, and the ability to use FDA-approved prescriptions—not on pretending the first appointment is cheap.

The flip side is just as real: because the clinician is not selling the next insertion, the dose can be changed without protecting a procedure sale. That does not guarantee better care. It removes one financial feature you should notice.

You have two clean next steps: compare current insurance and cash-pay models in our Midi vs Alloy vs Winona vs Evernow comparison, or use Find My HRT Path when your symptoms, uterus status, state, and insurance make the answer less obvious.

---

Who is SottoPelle actually right for?

Our editorial conclusion is that pellets fit a narrower group than the marketing suggests: women who have made an informed route comparison, strongly value infrequent dosing, accept cash-pay and limited short-term adjustability, and have a transparent local prescriber with a written monitoring and aftercare plan.

We would rather lose you honestly than keep you dishonestly. So here is the segmentation.

Pellets may genuinely fit your priorities if…

• You have discussed FDA-approved routes with a qualified clinician and still prefer an implant after understanding the evidence and regulatory difference.
• Daily or weekly adherence has repeatedly failed in real life, and infrequent dosing carries enough value to justify the tradeoffs.
• You can sustain the complete annual cash cost without depending on uncertain reimbursement.
• You have a local clinician who itemizes the first year, names the compounding facility, explains endometrial protection when relevant, and gives you a written plan for side effects and site problems.
• You understand that the first dose is not a trial you can casually switch off tomorrow.

That is a legitimate preference. Convenience has value. The page does not need to pretend otherwise to stay evidence-based.

Compare another route first if…

• You have not yet considered an FDA-approved patch, pill, gel, spray, ring, or vaginal treatment.
• Insurance coverage is a major part of making care sustainable.
• You want to adjust or stop the dose quickly.
• Your main symptoms are vaginal dryness, urinary symptoms, or pain with sex; low-dose vaginal estrogen is a different, local treatment question and may avoid systemic dosing.
• The clinic treats a lab number instead of explaining your symptoms, history, alternatives, and treatment target.
• The quote expires today, the pharmacy stays unnamed, or the staff will not put answers in writing.

The honest case for pellets

We are not going to only prosecute.

A small 1995 single-blind randomized trial assigned 34 postmenopausal women to estradiol implants alone or estradiol plus testosterone implants. The combined group showed greater improvement in several sexual-function measures and bone-density outcomes over the study period. Women with a uterus used cyclical oral progestins.

That trial shows the evidence is not zero. It was small, used a specific regimen, and does not settle the long-term safety or comparative-effectiveness questions around today's compounded commercial pellet programs.

Source: Davis et al., Maturitas 1995.

Put that beside the larger 2021 retrospective comparison, specialty recommendations against routine compounded therapy when approved options exist, and the inability to titrate an implant easily. Both columns belong in the decision.

Where to go when pellets are not your route

Your priority	Next page
Compare online menopause clinicians	Best online HRT providers for menopause
Compare insurance and cash-pay models	Midi vs Alloy vs Winona vs Evernow
Understand full HRT costs	HRT cost in 2026
Treat vaginal dryness or painful sex locally	Vaginal estrogen guide
Match route, insurance, symptoms, and state	Find My HRT Path

If pellets still look right after the hard parts—not before them—take the quote sheet to a local prescriber and make the clinic earn your yes.

---

What could make SottoPelle cost more than you planned?

SottoPelle can exceed the budget when the first-year insertion count rises, a booster or extra lab panel is added, a membership continues after treatment changes, or the dose or insertion site requires follow-up. The implant is less flexible to adjust than oral, transdermal, or topical routes, so the clinical tradeoff can become a cost tradeoff.

The dose is not readily adjustable after insertion

A patch can be removed. A pill or cream can be stopped under clinician direction. A pellet is designed to release over months.

The current Testopel label—again, a different FDA-approved testosterone product for male indications—states that pellet implantation is much less flexible for dose adjustment than oral or injectable administration. It also says pellets would have to be removed when complications require testosterone effects to stop.

ACOG's reason for recommending non-pellet testosterone preparations in women includes the inability to remove the pellet. Put together, the accurate language is not “pellets can never be removed.” It is: they are not readily titratable, and removal is not the simple routine equivalent of taking off a patch.

Ask:

“What is the plan if the dose is too high, too low, or causing side effects while the pellet is still active—and what part of that plan would I pay for?”

Higher hormone levels appeared in the comparative study

In the 2021 Jiang study, mean peak estradiol was 237.70 pg/mL in the pellet group versus 93.45 pg/mL in the FDA-approved group. Mean peak testosterone was 194.04 ng/dL versus 15.59 ng/dL.

The study also reported a higher overall incidence of documented side effects in the pellet group. Those data do not predict your result and are not SottoPelle-specific. They do make “we can always fix it next time” an incomplete answer when the current insertion remains active.

Androgenic effects such as acne, unwanted hair growth, or scalp-hair changes are more directly tied to testosterone exposure than to estradiol. A page that blames every effect on “high hormones” without separating the hormones is not being careful enough.

The cost line nobody can quote in advance

An extra examination. A repeat lab panel. An ultrasound, mammogram, biopsy, endometrial evaluation, medication change, or procedure.

The Jiang study recorded more abnormal uterine bleeding and more hysterectomy among pellet users in its intact-uterus subgroup. That does not let us assign a dollar figure to your risk or say a pellet caused every later intervention. It does prove that “complication cost: $0” would be invented certainty.

Get the aftercare policy, not a reassurance: who sees you, which visits are included, what the clinic can manage, what requires outside care, and whether replacement is charged.

---

The 15 questions to ask before you pay a SottoPelle clinic

Most incomplete pellet quotes are incomplete because the reader did not know which lines to request. These fifteen questions turn a headline insertion price into a written first-year care and cost plan, while exposing the booster, progestogen, compounding source, membership commitment, and aftercare terms before payment.

Print this or keep it open during the consultation.

1. Is the quoted amount per insertion, per pellet, or a package price?
2. Does that fee cover every prescribed pellet, the procedure, supplies, and anesthetic?
3. Is the initial consultation separate, and is any part credited toward treatment?
4. Are baseline labs included, and which lab bills them?
5. Are post-insertion labs included?
6. Are repeat labs required before every reinsertion?
7. Is a booster insertion part of your standard first-year process, under what circumstances, and what does it cost?
8. Is a follow-up visit included, and is it with the prescriber?
9. I have a uterus. If my plan includes systemic estrogen, what progestogen will protect the lining, in what form, and is it in this price?
10. How many insertions do women at this practice receive in the first 12 months, and what changes that number?
11. If a pellet extrudes or the site becomes infected, who sees me, what does the visit cost, and when is replacement included?
12. Is there a membership, minimum commitment, auto-renewal, cancellation process, or cancellation fee?
13. Do you submit insurance claims, provide a superbill, or accept HSA/FSA payment—and what documentation will I receive?
14. Which facility compounds the pellets, and is it a 503A pharmacy or registered 503B outsourcing facility?
15. What alternatives did you discuss, including FDA-approved routes appropriate to the same treatment goal?

Also verify, in about fifteen minutes

• The prescriber's active license and any public disciplinary history through the state licensing board.
• Who prescribes versus who performs the insertion.
• The compounding facility's exact legal name and current registration or license.
• How to reach a clinician if a problem appears after hours.
• Whether the quoted provider, location, and price match the documents you will sign.

Red flags worth walking away from

• “FDA-approved SottoPelle pellets for women.”
• “503B means FDA-approved.”
• “Natural, therefore safer.”
• Guaranteed symptom relief.
• Refusal to name the compounding facility.
• Refusal to itemize the quote.
• No discussion of alternatives.
• A membership described as though it includes treatment when it does not.
• A price that expires “today” without a documented public promotion.
• A testosterone offer that minimizes the prescription process or Schedule III status.

The five bold questions are the ones most likely to change the number. Ask those even if you skip the rest.

---

How The HRT Index verified these numbers

The current price rows come from first-party clinic pages or current indexed first-party listings; coverage findings come from payer policy pages; medical and regulatory statements come from FDA, federal regulations, specialty guidance, official labeling, and peer-reviewed literature. Every source type is labeled so an old fee sheet cannot masquerade as a current quote.

The HRT Index Verification Standard is the documented process by which The HRT Index reads every published price, separates FDA-approved from compounded options, verifies state availability and insurance, and re-checks on a fixed schedule: top providers monthly and the full roster quarterly.

We evaluate providers on exactly five pillars, always in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We do not assign numeric scores to providers, and there is no invented SottoPelle score on this page.

Our source hierarchy

1. FDA, federal regulations, official labeling, and authoritative specialty guidance for medical and regulatory claims.
2. First-party clinic and provider pages for current prices, inclusions, and terms.
3. Insurer policy pages, by policy number and date, for coverage findings.
4. Peer-reviewed literature for comparative outcomes and limitations.
5. Current search-index text only when a first-party page does not render usable text, with that limitation visible.
6. Public discussions only for language and decision friction—never for medical efficacy, safety, price, or coverage proof.

What we could not establish from public sources

• A national SottoPelle patient price. The network does not publish one.
• Your required dose or insertion frequency.
• The current price of every provider in the directory.
• Whether every indexed first-party price still appears at checkout today.
• The cancellation mechanics behind Tutera's public 12-month membership commitment.
• The exact first-year total until a clinic fills every line of the quote map.
• Independent, verified SottoPelle patient outcome data. We did not use testimonials as medical evidence.

What we changed during the audit

Date

Verified change

August 2026

Corrected the two-to-four-insertion annual range to $700–$1,700; rebuilt the price ledger around four current first-party sources; removed stale bundle pricing; relabeled Allura's booster documents as historical and conflicting; corrected Tutera's HRT membership from $99.99 to $49.99 monthly; replaced the six-policy claim with four accessible dated policies; tightened FDA, progestogen, lab-testing, controlled-substance, and comparative-evidence language.

Refresh plan

Element	Recheck cadence	Trigger
Clinic prices and inclusions	Monthly for rows used above	Price, package, lab, or URL change
Tutera membership	Monthly	Tier price, commitment, discount, or cancellation change
Provider availability and online-care pricing	Monthly	State, network, visit-price, or medication change
Insurer policies	Quarterly and on policy update	Review date, code table, coverage language, or plan-scope change
FDA status, labeling, and specialty guidance	Quarterly and event-driven	Approval, label, safety communication, or guideline update
Internal links and tools	On every page revision	URL, privacy policy, or matching-flow change

Read more about our methodology and how health information submitted to Find My HRT Path is handled in our consumer health data privacy policy.

---

SottoPelle cost: frequently asked questions

How much does SottoPelle cost per insertion for women?

Current first-party pages and indexed first-party listings show $350 to $425 per insertion for women, checked August 25, 2026. That is a small published sample, not a national average or a guarantee of your local price.

How much does SottoPelle cost per year?

Pellet insertion fees alone are $700 to $1,700 at two to four insertions using the current published band. At three to four insertions, the range is $1,050 to $1,700. Add every separately billed consultation, lab, prescription, membership, booster, and follow-up cost.

Why is my local SottoPelle quote higher than the prices here?

Dose, pellet count, region, insertion frequency, and inclusions can all move the price. A $500 quote with visits and labs may be less expensive over a year than a $350 quote that includes only the procedure. Compare line items, not the headline.

Are labs included in SottoPelle pricing?

It depends on the clinic. Austin says labs are required but does not say the $425 includes them; Gudgel's current indexed price says follow-up labs are included. Ask separately about baseline labs, post-insertion labs, repeat labs, draw fees, and insurance billing.

Does insurance cover SottoPelle?

None of the four current payer policies we reviewed supports routine coverage of implantable estradiol pellets for menopause. The policies classify the use as investigational, experimental, unproven, or non-covered. A consultation or standard lab claim may still be processed differently under your specific plan.

Can you use HSA or FSA money for SottoPelle?

A clinic may accept the card, but the account administrator determines eligibility. Get an itemized receipt and confirm any documentation requirement before relying on the account.

Is SottoPelle FDA-approved?

No FDA approval attaches to the SottoPelle brand or method. The pellets used for women are compounded finished drugs, which are not FDA-approved. “Bioidentical” does not change that status.

Is testosterone in SottoPelle a controlled substance?

Testosterone is a Schedule III controlled substance in the United States. It requires a prescription and a legitimate prescriber-patient process. There is no FDA-approved testosterone product indicated for women in the United States.

Do SottoPelle pellets include progesterone?

Do not assume they do. If you have a uterus and your plan includes systemic estrogen, ask which clinician-directed progestogen will protect the uterine lining, how it will be prescribed, and whether it is included in the quote.

How long do SottoPelle pellets last?

There is no universal interval. SottoPelle's public pages use women's ranges from about three months to as long as four to six months, and Tutera publishes a 3.5-insertion annual average. Your actual schedule must come from the treating clinician, and it controls how often you pay.

What is a booster insertion?

A booster is an additional insertion some clinics may use after the initial procedure. Two older Allura documents list a female booster at 5–7 weeks but disagree on the historical price—$215 in a September 2019 fee sheet and $185 in an undated FAQ. That is why you should ask your clinic rather than budget from an old document.

Is the Tutera membership the same as SottoPelle treatment?

No. Tutera's current Essential HRT + Aesthetics membership is $49.99 a month with a 12-month commitment, and products and services are purchased separately at member prices. The $99.99 price belongs to the separate Signature tier.

Is SottoPelle the same as BioTE?

No. They are different commercial training and provider-network businesses. Both may involve compounded pellets, but the local clinic, prescriber, product, compounding source, follow-up plan, and written price matter more than the logo.

Can SottoPelle be done online?

The insertion itself must be done in person. A clinic may handle intake or follow-up remotely where permitted, but a local professional must perform the procedure.

Is SottoPelle cheaper than an estradiol patch?

You cannot answer that honestly from one monthly sticker because the routes and clinical goals differ. SottoPelle's current public pellet-only band is $700–$1,700 at two to four insertions before extras; a patch adds a visit and pharmacy price that depends on insurance or cash-pay provider. Compare the full protocol and the exact medication status.

What if I decide not to continue after one insertion?

You can decline future insertions, but the pellet already placed continues releasing while active unless a clinician determines removal is necessary and feasible. If you joined a membership, the treatment decision does not automatically cancel the contract; check the written commitment and cancellation terms.

---

The bottom line

You came here with a per-insertion number. You now have the current published band, the correct two-to-four-insertion math, the four fee buckets, the dated booster documents, the insurer policy ledger, the corrected membership arithmetic, and the questions that turn a quote into a first-year plan.

That is enough to walk into a consultation and get a real number instead of a headline one. Which was the whole point.

Still not sure which HRT program is right for you? Use Find My HRT Path to get a personalized starting-point plan—and a flag when online care is not the right starting point.

---

Educational only — not medical advice. Discuss hormone therapy with a licensed clinician who knows your history.

Related on The HRT Index: Best Online HRT Providers for Menopause · Midi vs Alloy vs Winona vs Evernow · HRT Cost in 2026 · Vaginal Estrogen Guide · Find My HRT Path

Researched and produced by The HRT Index editorial team · Last verified: August 2026